about
beta 3: an additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kineticsExcitatory amino acid inhibitors for traumatic brain injuryAntiepileptic drugs and apoptotic neurodegeneration in the developing brainTraumatic brain injury: can the consequences be stopped?Aconitum and Delphinium sp. alkaloids as antagonist modulators of voltage-gated Na+ channels. AM1/DFT electronic structure investigations and QSAR studiesDibucaine mitigates spreading depolarization in human neocortical slices and prevents acute dendritic injury in the ischemic rodent neocortexIn vivo pharmacology of BIIR 561 CL, a novel combined antagonist of AMPA receptors and voltage-dependent Na(+) channelsStructures of muO-conotoxins from Conus marmoreus. I nhibitors of tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels in mammalian sensory neurons.Mechanism of action of two insect toxins huwentoxin-III and hainantoxin-VI on voltage-gated sodium channels.Role of voltage-gated Na+ channels in hypoxia-induced neuronal injuries.5-Hydroxytryptamine1A agonists: potential use in glaucoma. Evidence from animal studies.SKF83959 suppresses excitatory synaptic transmission in rat hippocampus via a dopamine receptor-independent mechanism.Targeting α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy.Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressurePotent inhibition of anoxic depolarization by the sodium channel blocker dibucaine.The hoiamides, structurally intriguing neurotoxic lipopeptides from Papua New Guinea marine cyanobacteria.Potent blockade of sodium channels and protection of brain tissue from ischemia by BIII 890 CL.Anti-inflammatory role of fetuin-A in injury and infection.Ischemic neuronal cell death and organellae damage.Deletion of TRPC6 Attenuates NMDA Receptor-Mediated Ca2+ Entry and Ca2+-Induced Neurotoxicity Following Cerebral Ischemia and Oxygen-Glucose Deprivation.New AMPA antagonists in epilepsy.Scutellarin as a Potential Therapeutic Agent for Microglia-Mediated Neuroinflammation in Cerebral Ischemia.Distinct domains of the sodium channel beta3-subunit modulate channel-gating kinetics and subcellular location.Identification and preclinical testing of novel antiepileptic compounds.Which form of dopamine is the substrate for the human dopamine transporter: the cationic or the uncharged species?Volume-sensitive chloride channels blocked by neuroprotective drugs in human glial cells (U-138MG).Molecular mechanism of action and safety of 5-(3-chlorophenyl)-4-hexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione - a novel anticonvulsant drug candidate.Biophysical properties and slow voltage-dependent inactivation of a sustained sodium current in entorhinal cortex layer-II principal neurons: a whole-cell and single-channel study.Fine gating properties of channels responsible for persistent sodium current generation in entorhinal cortex neurons.Role of serum- and glucocorticoid-inducible kinases in stroke.Hoiamide a, a sodium channel activator of unusual architecture from a consortium of two papua new Guinea cyanobacteria.Enzyme-luminescence method: Tool for real-time monitoring of natural neurotoxins in vitro and l-glutamate release from primary cortical neurons.Contribution of presynaptic Na(+) channel inactivation to paired-pulse synaptic depression in cultured hippocampal neurons.Thromboxane receptor stimulation associated with loss of SKCa activity and reduced EDHF responses in the rat isolated mesenteric artery.Mechanism of the persistent sodium current activator veratridine-evoked Ca elevation: implication for epilepsy.Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia.Ischemic stroke in elderly patients treated with a free radical scavenger-glycolytic intermediate solution: a preliminary pilot trial.Molecular basis for exaggerated sensitivity to mexiletine in the cardiac isoform of the fast Na channel.Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity.Riluzole, an inhibitor of glutamatergic transmission, suppresses levodopa-induced rotations in 6-hydroxydopamine-lesioned rats.
P2860
Q22253235-3D534858-5361-4EFD-97D0-003ECBF6EFAEQ24203796-81CFEC0C-6FFC-402E-AE95-D000776F6DACQ24538604-FFB7BC1C-790E-497E-804F-828C726F1834Q24655846-135D9A31-0071-44C2-9650-4D9890FCB547Q26779498-D9737D63-18B8-45F4-A165-6DA968A84D5FQ27331575-FB35A8AC-C9AE-4399-BB88-84E3B56EF81BQ28343897-B1A94E4F-76FB-4A87-8D27-1746E9EFFF99Q30916250-AA908AD5-AFC4-4DD5-8098-42CCAE556B40Q33892657-4316B21E-F744-4909-BFDD-D4131E21846BQ33972501-875A7B67-AE99-4C4B-80DA-FB8A72EAAA2EQ34057619-2D943061-6B00-4AD4-910C-B3A6739F717CQ34182064-0024A160-8211-470C-AFEF-2AB011360F69Q34395565-AB466A43-B1D8-4A12-ACF2-CA86EF29625CQ34658800-5323FB4D-CDDB-40A1-A1F3-75536C2567E0Q34785671-169EF5C5-717B-4E27-83BC-0C593B0FDBE8Q35582617-9737F3FB-DAEF-4641-B5A8-0E8BCE3218C2Q35700595-BEAA451B-4B02-4AF5-8780-7730EDAB340EQ35951563-78B920C9-C532-46C7-AB73-F071EEBF0E05Q36052703-5B2C9496-7CB1-409A-8727-BF37FB738AD4Q37723488-D313ABF5-414C-424E-9277-AD74AA0CF6F9Q38025721-DCD72DD3-491C-4BE0-A938-252320C686B5Q38814573-A5AB3D84-9F2F-4AFE-A2F4-B2C511817422Q40678733-8AFB47BA-A29A-49AF-8DDA-80FB90A60DC0Q40908835-A6A4216C-96E8-4D34-8786-B5140F89D285Q40973659-5CD94758-734C-4448-B886-9D794A63A996Q41170148-66F2E21A-8C5A-4725-9B48-D9FB555E1FFBQ41454841-7B46F7B9-D09E-4AC8-AB03-3BF59AB08CDEQ41938559-C73A98FA-2D5A-4D40-A6D1-570916D027BDQ41939072-897697B6-1F11-4E11-B2A1-02C579809624Q41984567-392D2A5A-55F5-43D9-9875-6CB981D0EDA5Q42120421-C14E6E7D-5379-428A-9328-C873A1EC0762Q42187318-07C0F5A6-A064-436E-9394-BA822D15B577Q42516785-8ED6F29E-4CBD-47E7-BBB2-086F50A6F1B8Q43089908-5101E47D-1A5C-4D65-83D4-9018DEB00EE5Q43283100-753F8EFD-D926-402E-9847-3E9E8BD80D01Q43706820-4C2D49C8-0295-4FA7-9B4A-830CD0DDC667Q43849369-217C5090-75FF-497B-9385-6F8BF3BA2F76Q43923816-2D1CBD59-9E7A-40C6-8996-6218D673B58EQ44112140-4ECA08B9-0B81-4E34-95DC-7388ACFEDD59Q44492712-D5168BB9-884E-4C5D-AA08-78F91B3D5A4E
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Na+ channels as targets for neuroprotective drugs.
@en
type
label
Na+ channels as targets for neuroprotective drugs.
@en
prefLabel
Na+ channels as targets for neuroprotective drugs.
@en
P1476
Na+ channels as targets for neuroprotective drugs.
@en
P2093
P304
P356
10.1016/S0165-6147(00)89060-4
P577
1995-09-01T00:00:00Z